Development of Targeted Alpha Therapy from Bench to Bedside
This review briefly describes recent promising developments of alpha emitter labelled compounds for targeted alpha therapy of bladder cancer, brain tumours, neuroendocrine tumours, and prostate cancer.
Gespeichert in:
Veröffentlicht in: | Journal of medical imaging and radiation sciences 2019-12, Vol.50 (4), p.S18-S20 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | S20 |
---|---|
container_issue | 4 |
container_start_page | S18 |
container_title | Journal of medical imaging and radiation sciences |
container_volume | 50 |
creator | Morgenstern, Alfred Bruchertseifer, Frank |
description | This review briefly describes recent promising developments of alpha emitter labelled compounds for targeted alpha therapy of bladder cancer, brain tumours, neuroendocrine tumours, and prostate cancer. |
doi_str_mv | 10.1016/j.jmir.2019.06.046 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2272732964</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1939865419303418</els_id><sourcerecordid>2272732964</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-29ea3ed763ca18890498059911d206796634b2837973f761fd0aecdf2d3013e23</originalsourceid><addsrcrecordid>eNp9kDtPwzAUhS0EoqXwBxhQRpYEP1I_BEspT6kSS5kt176hqZI62Gml_ntctTAy3TN850j3Q-ia4IJgwu9WxaqtQ0ExUQXmBS75CRoSKXgulKSnKSumcsnH5QBdxLjCmFMh1DkaMFLisSRyiO6fYAuN71pY95mvsrkJX9CDyyZNtzTZfAnBdLusCr7NHmFtl1nvU3CxdnCJzirTRLg63hH6fHmeT9_y2cfr-3Qyy21JaZ9TBYaBE5xZQ6RUuFQSj5UixFHMheKclQsqmVCCVYKTymED1lXUMUwYUDZCt4fdLvjvDcRet3W00DRmDX4TNaWCCkYVLxNKD6gNPsYAle5C3Zqw0wTrvTS90ntpei9NY66TtFS6Oe5vFi24v8qvpQQ8HABIX25rCDraOskAVwewvXa-_m__B4a8e1M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2272732964</pqid></control><display><type>article</type><title>Development of Targeted Alpha Therapy from Bench to Bedside</title><source>Access via ScienceDirect (Elsevier)</source><creator>Morgenstern, Alfred ; Bruchertseifer, Frank</creator><creatorcontrib>Morgenstern, Alfred ; Bruchertseifer, Frank</creatorcontrib><description>This review briefly describes recent promising developments of alpha emitter labelled compounds for targeted alpha therapy of bladder cancer, brain tumours, neuroendocrine tumours, and prostate cancer.</description><identifier>ISSN: 1939-8654</identifier><identifier>EISSN: 1876-7982</identifier><identifier>DOI: 10.1016/j.jmir.2019.06.046</identifier><identifier>PMID: 31405818</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>actinium-225 ; alpha emitter ; bismuth-213 ; clinical application ; Targeted alpha therapy</subject><ispartof>Journal of medical imaging and radiation sciences, 2019-12, Vol.50 (4), p.S18-S20</ispartof><rights>2019</rights><rights>Copyright © 2019. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-29ea3ed763ca18890498059911d206796634b2837973f761fd0aecdf2d3013e23</citedby><cites>FETCH-LOGICAL-c422t-29ea3ed763ca18890498059911d206796634b2837973f761fd0aecdf2d3013e23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jmir.2019.06.046$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31405818$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Morgenstern, Alfred</creatorcontrib><creatorcontrib>Bruchertseifer, Frank</creatorcontrib><title>Development of Targeted Alpha Therapy from Bench to Bedside</title><title>Journal of medical imaging and radiation sciences</title><addtitle>J Med Imaging Radiat Sci</addtitle><description>This review briefly describes recent promising developments of alpha emitter labelled compounds for targeted alpha therapy of bladder cancer, brain tumours, neuroendocrine tumours, and prostate cancer.</description><subject>actinium-225</subject><subject>alpha emitter</subject><subject>bismuth-213</subject><subject>clinical application</subject><subject>Targeted alpha therapy</subject><issn>1939-8654</issn><issn>1876-7982</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kDtPwzAUhS0EoqXwBxhQRpYEP1I_BEspT6kSS5kt176hqZI62Gml_ntctTAy3TN850j3Q-ia4IJgwu9WxaqtQ0ExUQXmBS75CRoSKXgulKSnKSumcsnH5QBdxLjCmFMh1DkaMFLisSRyiO6fYAuN71pY95mvsrkJX9CDyyZNtzTZfAnBdLusCr7NHmFtl1nvU3CxdnCJzirTRLg63hH6fHmeT9_y2cfr-3Qyy21JaZ9TBYaBE5xZQ6RUuFQSj5UixFHMheKclQsqmVCCVYKTymED1lXUMUwYUDZCt4fdLvjvDcRet3W00DRmDX4TNaWCCkYVLxNKD6gNPsYAle5C3Zqw0wTrvTS90ntpei9NY66TtFS6Oe5vFi24v8qvpQQ8HABIX25rCDraOskAVwewvXa-_m__B4a8e1M</recordid><startdate>201912</startdate><enddate>201912</enddate><creator>Morgenstern, Alfred</creator><creator>Bruchertseifer, Frank</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201912</creationdate><title>Development of Targeted Alpha Therapy from Bench to Bedside</title><author>Morgenstern, Alfred ; Bruchertseifer, Frank</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-29ea3ed763ca18890498059911d206796634b2837973f761fd0aecdf2d3013e23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>actinium-225</topic><topic>alpha emitter</topic><topic>bismuth-213</topic><topic>clinical application</topic><topic>Targeted alpha therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morgenstern, Alfred</creatorcontrib><creatorcontrib>Bruchertseifer, Frank</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medical imaging and radiation sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morgenstern, Alfred</au><au>Bruchertseifer, Frank</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of Targeted Alpha Therapy from Bench to Bedside</atitle><jtitle>Journal of medical imaging and radiation sciences</jtitle><addtitle>J Med Imaging Radiat Sci</addtitle><date>2019-12</date><risdate>2019</risdate><volume>50</volume><issue>4</issue><spage>S18</spage><epage>S20</epage><pages>S18-S20</pages><issn>1939-8654</issn><eissn>1876-7982</eissn><abstract>This review briefly describes recent promising developments of alpha emitter labelled compounds for targeted alpha therapy of bladder cancer, brain tumours, neuroendocrine tumours, and prostate cancer.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31405818</pmid><doi>10.1016/j.jmir.2019.06.046</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1939-8654 |
ispartof | Journal of medical imaging and radiation sciences, 2019-12, Vol.50 (4), p.S18-S20 |
issn | 1939-8654 1876-7982 |
language | eng |
recordid | cdi_proquest_miscellaneous_2272732964 |
source | Access via ScienceDirect (Elsevier) |
subjects | actinium-225 alpha emitter bismuth-213 clinical application Targeted alpha therapy |
title | Development of Targeted Alpha Therapy from Bench to Bedside |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T10%3A27%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20Targeted%20Alpha%20Therapy%20from%20Bench%20to%20Bedside&rft.jtitle=Journal%20of%20medical%20imaging%20and%20radiation%20sciences&rft.au=Morgenstern,%20Alfred&rft.date=2019-12&rft.volume=50&rft.issue=4&rft.spage=S18&rft.epage=S20&rft.pages=S18-S20&rft.issn=1939-8654&rft.eissn=1876-7982&rft_id=info:doi/10.1016/j.jmir.2019.06.046&rft_dat=%3Cproquest_cross%3E2272732964%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2272732964&rft_id=info:pmid/31405818&rft_els_id=S1939865419303418&rfr_iscdi=true |